Page last updated: 2024-08-26

3,4-dihydroxyphenylglycol and Cocaine Abuse

3,4-dihydroxyphenylglycol has been researched along with Cocaine Abuse in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Scheyer, AF; Tseng, KY; Wolf, ME1
Ben-Shahar, O; Caruana, AL; Ditzhazy, J; Gordon, EJ; Kippin, TE; Miller, BW; Ploense, KL; Sacramento, AD; Silva, HE; Szumlinski, KK; Webb, SM; Wroten, MG1

Other Studies

2 other study(ies) available for 3,4-dihydroxyphenylglycol and Cocaine Abuse

ArticleYear
A protein synthesis-dependent mechanism sustains calcium-permeable AMPA receptor transmission in nucleus accumbens synapses during withdrawal from cocaine self-administration.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2014, Feb-19, Volume: 34, Issue:8

    Topics: Animals; Benzoates; Calcium; Cocaine-Related Disorders; Cycloheximide; Excitatory Amino Acid Antagonists; Glycine; Male; Methoxyhydroxyphenylglycol; Nucleus Accumbens; Patch-Clamp Techniques; Protein Biosynthesis; Protein Synthesis Inhibitors; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Self Administration; Substance Withdrawal Syndrome; Synapses; Synaptic Transmission; Thiazoles; Ventral Tegmental Area

2014
Deficits in ventromedial prefrontal cortex group 1 metabotropic glutamate receptor function mediate resistance to extinction during protracted withdrawal from an extensive history of cocaine self-administration.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2013, Jan-09, Volume: 33, Issue:2

    Topics: Animals; Blotting, Western; Cocaine-Related Disorders; Conditioning, Operant; Cues; Excitatory Amino Acid Antagonists; Extinction, Psychological; Injections; Male; Methoxyhydroxyphenylglycol; Prefrontal Cortex; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Recurrence; Self Administration; Substance Withdrawal Syndrome

2013